FA
IMPV

Friess Associates’s Imperva, Inc. IMPV Stock Holding History

Friess Associates’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-59,100
Closed -$3.74M – 180
2015
Q4 		$3.74M Buy
59,100
+50,000
+549% +$3.4M 0.35% 80
2015
Q3 		$596K Buy
+9,100
New +$604K 0.06% 103

Other funds holding IMPV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Friess Associates's IMPV Position: Q1 2016 in Review

Friess Associates sold out of Imperva, Inc. (IMPV) in Q1 2016, closing a stake of 59,100 shares — an estimated $3.74M sold.

Friess Associates first reported a position in IMPV in Q3 2015 and held it in 2 quarters. The position peaked at $3.74M in Q4 2015. 160 funds tracked by Wall St. Rank hold IMPV as of Q1 2016.

  • Friess Associates reported no remaining Imperva, Inc. position as of Q1 2016 after selling out during the quarter.
  • Friess Associates sold 59,100 Imperva, Inc. shares in Q1 2016, an estimated $3.74M.
  • Friess Associates first reported a position in Imperva, Inc. in Q3 2015 and held it in 2 quarters.
  • Friess Associates's Imperva, Inc. position peaked at $3.74M in Q4 2015.
  • 160 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2016.

Based on Friess Associates's 13F filing for Q1 2016, filed 13 May 2016.